olive oil; soybean oil · Baxter Hlthcare Corp · NDA 204508
Clinolipid 20%
Earliest generic entry, as listed
24 Apr 2027
Blocked by exclusivity: NPP.
Listed patents · 0 unexpired
No unexpired patents listed.
Exclusivities · 1 unexpired
| NPP | new patient population | 24 Apr 2027 |
Paragraph IV certifications · 0
No Paragraph IV certification listed by FDA for this drug.
The list shows that a generic applicant certified to FDA that a listed patent is invalid or not infringed. It does not show litigation, settlements or launch timing.
Event history
- 24 Oct 2026Enters 12-month window basis: exclusivity · 204508-00124 Apr 2027
Products covered · 1
| NDA · product | Form | Strength | Listed expiry |
|---|---|---|---|
| 204508 · 001 · RLD | emulsion, intravenous | 16%(160GM/1000ML);4% (40GM/1000ML) | 24 Apr 2027 |